Startups: India’s next big bet on pharma innovation?
While India’s pharma startups can resolve scientific and systemic blind spots, funding remains the missing link blocking scalable…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Deloitte India
Pharma’s strategic path to growth in the nutra maze
The nutraceutical market is a thriving ecosystem of opportunities. For pharma companies, it’s a space where the allure of a $11.55…
Accelerating pharma’s sustainability efforts
Avinaw Prasad, Director, Climate Change & Sustainability, Deloitte India explains why integrating sustainability into the core…
Decoding Budget 2024-25: A lacklustre budget for pharma
The Finance Minister announced the Budget for 2024-25 on July 23, during the Monsoon Session of Parliament
Union Budget 2023: Industry lauds focus on R&D
Pharma leaders and experts share their views on Union Budget 2023 and give insights on the impact of the measures
What can Indian Pharma Inc do to respond, recover and thrive in times of COVID-19?
As pharma companies grapple with the ongoing COVID-19 crisis, there are certain necessary measures that leaders will need to take…
Lifesciences sector growth appears to have outpaced compliance management processes: Deloitte report
Around 48 per cent of survey respondents confirmed that compliance strategy was not a key area earmarked for investment in their…